Sign In
Buy AYTU
$2.23
+0.0800 (+3.72%)
At Close: Jul 31, 2026
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Aytu Bioscience Inc (AYTU) Outpaces Stock Market Gains: What You Should Know
09:45pm, Thursday, 07'th May 2020
Aytu Bioscience Inc (AYTU) closed the most recent trading day at $1.47, moving +1.38% from the previous trading session.
Aytu BioScience to Report Fiscal Q3 FY 2020 Results and Business Update
12:00pm, Thursday, 07'th May 2020
ENGLEWOOD, CO / ACCESSWIRE / May 7, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant ..
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aytu BioSciences, Inc. - AYTU
09:46pm, Tuesday, 05'th May 2020
Pomerantz LLP is investigating claims on behalf of investors of Aytu BioSciences, Inc. (“Aytu” or the “Company”) (NASDAQ: AYTU). Such investors are advised to contact Robert S. Willoughby at
Aytu Bioscience, Inc. (AYTU) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
04:30pm, Tuesday, 05'th May 2020
Aytu Bioscience, Inc. (AYTU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Column: How Cedars-Sinai got sucked into the battle over Trump's claim of a COVID-19 treatment
01:00pm, Friday, 01'st May 2020
Cedars-Sinai is embroiled in a political battle over Trump's remarks on a potential virus treatment.
How Are Coronavirus Trades Changing?
04:00pm, Thursday, 30'th Apr 2020
The market's still WILD and coronavirus is at the center of it all. So how are coronavirus trades changing and how can you adapt?
RDS.A, LYG among premarket losers
01:19pm, Thursday, 30'th Apr 2020
Chesapeake Energy (NYSE:CHK) -43% after preparing bankruptcy filing.On Deck Capital (NYSE:ONDK) -19% on Q1 earnings.Capricor Therapeutics (NASDAQ:CAPR) -16%.Capstead Mortgage (NYSE:CMO) -13% on
FDA Expediting Accelerated Development of Novel Therapies for COVID-19
12:00pm, Tuesday, 28'th Apr 2020
The U.S. Federal government is working closely with companies and researchers to find treatments and vaccines to overcome the global health crisis. The FDA has been cutting red tape and has launched n
96 Biggest Movers From Yesterday
08:22am, Tuesday, 28'th Apr 2020
Gainers
Naked Brand Group Limited (NASDAQ: NAKD) shares climbed 60.8% to close at $0.78 on Monday after climbing 8% on Friday.
Yield10 Bioscience, Inc. (NASDAQ: YTEN) shares...
What's in Store for Aytu BioScience's (AYTU) Q3 Earnings?
04:25pm, Monday, 27'th Apr 2020
On Aytu BioScience's (AYTU) upcoming earnings call, investor focus will be on its distribution right to commercialize the COVID-19 IgG/IgM Rapid Test in North America.
AMRN, EPR among top gainers
01:21pm, Monday, 27'th Apr 2020
Axsome Therapeutics (NASDAQ:AXSM) +44% as Axsome's lead candidate successful in Alzheimer's study.Avadel Pharmaceuticals plc (NASDAQ:AVDL) +34% on positive data on lead drug.Yield10 Bioscience (NA
CHK, BYND among premarket gainers
01:15pm, Friday, 24'th Apr 2020
Mesoblast (NASDAQ:MESO) +119% as cell therapy shows significant benefit in COVID-19 patients.Medigus (NASDAQ:MDGS) +73% on COVID-19 plan.Pluristem Therapeutics (NASDAQ:PSTI) +20% on €50 capital r
LVS, INO among premarket gainers
01:21pm, Thursday, 23'rd Apr 2020
CounterPath (NASDAQ:CPAH) +91% on Q4 update.Borqs Technologies (NASDAQ:BRQS) +22% on launching mobile smart tracking cloud solution.Immunomedics (NASDAQ:IMMU) +34% as FDA gave approval to its trea
Aytu BioScience: A Corona-Portunist With 40%+ Downside
02:00pm, Monday, 20'th Apr 2020
Aytu BioSciences' shares have unjustifiably risen on the company's announcement of a licensing deal to distribute a COVID-19 test in the U.S. Aytu is selling th
